Noxilizer Announces Mike Valentine, Vice President of North American Sales
Noxilizer, the company advancing a unique and superior, room temperature NO2-based sterilisation technology for life science manufacturers, is pleased to announce the appointment of Mr Michael Valentine as vice president of North American sales.
“Mike brings over 20 years of distinguished experience in sales and customer relationship management to the Noxilizer team,” notes president and CEO, Lawrence Bruder. “He has a well-established reputation in the medical device sterilisation market. Combined with extensive experience initiating start-up activities for business units and building technical sales teams, Mike will catapult our sales effort and rapidly advance the adoption of NO2 instrument, consumable and contract sterilization in the US market.”
Mike has a history of building strong working relationships with customers throughout an impressive professional career with leading medical device manufacturers of sterilisation equipment and services including: Getinge USA, Advanced Sterilisation Products (ASP), a Johnson & Johnson Company, and Medivators Corporation. Most recently, Mike served as director of infection prevention and control chemistries for medivators corporation, building the contract sterilisation business for single use products. Prior to Medivators, he was instrumental in developing the Life Science business unit for ASP. Mike earned a Bachelor of Science in Electrical Engineering (BSEE) from the University of Massachusetts at Amherst.
“I am fortunate to join a dedicated and talented team at Noxilizer. I look forward to advancing the most innovative sterilisation solution in years, to the market I have spent most of my life serving,” says Valentine. “Alternative sterilisation technologies are providing new possibilities. Customers are already recognising the value of NO2 technology and benefitting from the contract sterilization services and in-house use of the RTS 360 Industrial NO2 Sterilizer.” NO2 is highly-compatible with a wide range of temperature-sensitive products like bioresorbable implants, prefilled syringes and other drug-device combination products. It provides a safer, simpler, more economical alternative for manufacturers.
Mike will be building out the Noxilizer sales team this fall. And as Noxilizer completes the installation of multiple sterilization units to customers, additional hiring to support the growing commercial organization will take place.